As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 1/26/24  NeuBase Therapeutics, Inc.        8-K:1,9     1/26/24   11:249K                                   Toppan Merrill/FA        
10/18/23  NeuBase Therapeutics, Inc.        8-K:1,9    10/17/23   12:418K                                   Toppan Merrill/FA        
 6/30/23  NeuBase Therapeutics, Inc.        8-K:1,3,8,9 6/28/23   21:1.6M                                   Toppan Merrill/FA        
12/29/22  NeuBase Therapeutics, Inc.        8-K:1,9    12/28/22   11:379K                                   Toppan Merrill/FA        
 8/27/21  NeuBase Therapeutics, Inc.        8-K:1,9     8/27/21   12:503K                                   Toppan Merrill/FA        
 4/27/21  NeuBase Therapeutics, Inc.        8-K:1,2,9   4/21/21    2:65K                                    Toppan Merrill/FA        
 4/22/21  NeuBase Therapeutics, Inc.        8-K:1,8,9   4/22/21    4:362K                                   Toppan Merrill/FA        
 10/6/20  NeuBase Therapeutics, Inc.        8-K:1,2     10/2/20    1:21K                                    Toppan Merrill/FA        
 4/29/20‡ NeuBase Therapeutics, Inc.        8-K:1,8,9   4/28/20    4:390K                                   Toppan Merrill/FA        
 7/12/19  NeuBase Therapeutics, Inc.        8-K:1,2,3,5 7/12/19    5:522K                                   Quality EDGAR So… LLC/FA 
  7/3/19  NeuBase Therapeutics, Inc.        8-K:1,8,9   6/27/19    3:95K                                    Quality EDGAR So… LLC/FA 
  1/3/19  NeuBase Therapeutics, Inc.        8-K:1,2,5,7  1/2/19    8:7.3M                                   Quality EDGAR So… LLC/FA 
  4/6/17  NeuBase Therapeutics, Inc.        8-K:1,9      4/5/17    6:552K                                   Quality EDGAR So… LLC/FA 
 12/8/16  NeuBase Therapeutics, Inc.        8-K:1,2,9   12/7/16    8:562K                                   Quality EDGAR So… LLC/FA 
  2/6/15  NeuBase Therapeutics, Inc.        8-K:1,8,9    2/5/15    4:290K                                   Quality EDGAR So… LLC/FA 
 1/20/15  NeuBase Therapeutics, Inc.        8-K:1,9     1/15/15    2:24K                                    Quality EDGAR So… LLC/FA 
  6/2/14  NeuBase Therapeutics, Inc.        8-K:1,2,8,9 5/27/14    7:278K                                   Quality EDGAR So… LLC/FA 
 5/16/14  NeuBase Therapeutics, Inc.        8-K:1,9     5/14/14    3:544K                                   Quality EDGAR So… LLC/FA 
  4/8/14  NeuBase Therapeutics, Inc.        8-K:1,8,9    4/8/14    5:259K                                   Quality EDGAR So… LLC/FA 
 3/14/14  NeuBase Therapeutics, Inc.        8-K:1,8,9   3/11/14    2:39K                                    Quality EDGAR So… LLC/FA 

____________
‡	A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET.  The legal “Filed As Of” date may be the next, or another, day.
¹	Filing/Form Type:  /A
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.